Public Health Emergency of International Concern (PHEIC)
Polio this week as of 24 July 2018 [GPEI]
:: Strengthening vaccine trust in Pakistan: How a vaccine refuser became an advocate for polio eradication.
:: Disease surveillance innovations help defeat the poliovirus: Across the Lake Chad Basin, e-Surve technology is reshaping the way that the polio programme conducts disease surveillance.

Summary of new cases this week:
::   Following advance notification last week, one wild poliovirus type 1 (WPV1) case in Chawkay district, Kunar province, has been confirmed. The case had onset of paralysis on 22 June.
:: Five new WPV1 positive environmental samples were reported in the past week. Two samples were collected in Kabul province on 26 June, two samples were collected in Kandahar province, one on 26 June and one on 5 July, and one sample was collected in Nangarhar province, on 26 June.
:: Three new WPV1 positive environmental samples were reported in the past week. All samples were collected on 10 July, one in Islamabad province, one in Khyber Pakhtunkhwa province and one in Punjab province.
:: Two cVDPV2 positive environmental samples detected in Sokoto State have been confirmed, following advance notification last week. The samples were collected on 5 June and 12 June.


WHO Grade 3 Emergencies  [to 28 Jul 2018]
:: WHO airlifts 168 tonnes of life-saving medicines and medical supplies to Yemen
20 July 2018— Seven WHO-chartered aircraft have landed in Sana’a Airport this week, while between 30 to 50 tonnes of medicines and medical supplies reach Aden regularly by a UN ship run by the World Food Programme (WFP). In total this week more than 200 tonnes of life-saving medicines and medical supplies, and emergency equipment have been delivered in Yemen by WHO, in partnership with WFP and the logistic cluster, as health needs in Yemen grow at an alarming pace.
The shipments contain Interagency Emergency Health Kits (IEHK), surgical kits, cholera kits, intravenous (IV) fluids and various types of antibiotics which are much-needed by health facilities across the country, particularly in Hudaydah and Aden. Around 120 tonnes of these supplies will be distributed to Al Hudaydah as part of WHO plans to scale up health interventions in the governorates affected by the recent intensification of the military operations…

Iraq  – No new announcements identified
Nigeria  – No new announcements identified
South Sudan  – No new announcements identified
The Syrian Arab Republic – No new announcements identified
WHO Grade 2 Emergencies  [to 28 Jul 2018]
[Several emergency pages were not available at inquiry]
Cameroon  – No new announcements identified
Central African Republic  No new announcements identified.
Democratic Republic of the Congo  No new announcements identified
Ethiopia  No new announcements identified.
LibyaNo new announcements identified.
Myanmar  – No new announcements identified
Niger  – No new announcements identified.
UkraineNo new announcements identified.

UN OCHA – L3 Emergencies
The UN and its humanitarian partners are currently responding to three ‘L3’ emergencies. This is the global humanitarian system’s classification for the response to the most severe, large-scale humanitarian crises. 
Syrian Arab Republic 
:: Syrian Arab Republic: Dar’a, Quneitra, As-Sweida Situation Report No. 4 as of 26 July 2018

:: Yemen: Al Hudaydah Update Situation Report No. 9 – Reporting Period: 14 – 24 July 2018


UN OCHA – Corporate Emergencies
When the USG/ERC declares a Corporate Emergency Response, all OCHA offices, branches and sections provide their full support to response activities both at HQ and in the field.
Ethiopia  No new announcements identified.
Somalia   – No new announcements identified.

Editor’s Note:
We will cluster these recent emergencies as below and continue to monitor the WHO webpages for updates and key developments.

EBOLA/EVD  [to 28 Jul 2018]
:: Ebola outbreak in DRC ends: WHO calls for international efforts to stop other deadly outbreaks in the country  24 July 2018
[See Milestones/Perspectives above for more detail]

MERS-CoV [to 28 Jul 2018]
:: MERS situation update, June 2018
:: At the end of June 2018, a total of 2229 laboratory-confirmed cases of Middle East respiratory syndrome (MERS), including 791 associated deaths (case–fatality rate: 35.5%) were reported globally; the majority of these cases were reported from Saudi Arabia (1853 cases, including 717 related deaths with a case–fatality rate of 38.7%).
:: During the month of June, a total of 4 laboratory-confirmed cases of MERS were reported in Saudi Arabia including 1 associated death (case-fatality rate: 25%). No healthcare associated transmission or hospital outbreak was reported during this month.
:: The demographic and epidemiological characteristics of reported cases, when compared during the same corresponding period of 2013 to 2018, do not show any significant difference or change. Owing to improved infection prevention and control practices in hospitals, the number of hospital-acquired cases of MERS has dropped significantly since 2015.
:: The age group 50–59 years continues to be at highest risk for acquiring infection of primary cases. The age group 30–39 years is most at risk for secondary cases. The number of deaths is higher in the age group 50–59 years for primary cases and 70–79 years for secondary cases.
Yellow Fever  [to 28 Jul 2018]
No new announcements identified.
Zika virus  [to 28 Jul 2018]
:: Progress toward discovery of Zika virus vaccines and therapeutics
23 July 2018
…Studies in animal models have shown promising results of Zika virus vaccines for preventing maternal-fetal transmission and generating immunity in the vaccine recipient, but further validation is still required in clinical settings. Several vaccine candidates are currently in phase 1 and 2 of human clinical trials, summarized in the WHO vaccine pipeline tracker.
Many hurdles remain, however, before a vaccine will become available. The limited number of cases occurring globally limits the ability of studies to evaluate the protective effects of vaccines in phase 3 human trials. To prepare sites for future clinical trials, mathematical modelling is being used to predict when and where potential future Zika outbreaks may occur, but accurately predicting and preparing sites for future multi-centre clinical trials present unique logistical challenges. In the absence of a suitable population and/or environment to test a candidate vaccine, other options for clinical evaluation are being considered…
:: Zika vaccines and therapeutics: landscape analysis and challenges ahead
Wilder-Smith A, Vannice K, Durbin A, Hombach J, Thomas SJ, Thevarjan I, Simmons CP. BMC Med. 2018 Jun; 16(1):84.


WHO & Regional Offices [to 28 Jul 2018]  

WHO & Regional Offices [to 28 Jul 2018]

Ebola outbreak in DRC ends: WHO calls for international efforts to stop other deadly outbreaks in the country  24 July 2018
[See Milestones/Perspectives above for more detail]


Weekly Epidemiological Record, 20 July 2018, vol. 93, 29/30 (pp. 388–396)
:: Global Advisory Committee on Vaccine Safety, 6–7 June 2018
WHO Regional Offices
Selected Press Releases, Announcements
WHO African Region AFRO
Selected Featured News
:: No Vaccine Derived Polio Outbreak in Uganda  27 July 2018
South Sudan strengthens preparedness and response for Ebola and other deadly diseases through Emergency risk communication   27 July 2018
WHO Director General: Republic of Congo can transform its primary health care into a model for other nations  27 July 2018
Nigeria to avert over 160,000 deaths in children yearly, with introduction of rotavirus vaccine into immunization schedule.  24 July 2018

WHO Region of the Americas PAHO
:: New course to improve nutrition programs in Latin America and the Caribbean (07/25/2018)
WHO South-East Asia Region SEARO
No new announcements identified.
WHO European Region EURO
:: Universal access to testing and treatment is key to eliminating viral hepatitis 26-07-2018
:: Toolkit to help European Region move towards sustainable health workforce now available online 26-07-2018
:: WHO calls for urgent action to accelerate HIV response in eastern Europe and central Asia 23-07-2018

WHO Eastern Mediterranean Region EMRO
:: WHO thanks Kuwait for the generous support to the people of Yemen  26 July 2018

WHO Western Pacific Region
:: Candidates announced for next WHO Regional Director for the Western Pacific
MANILA, 27 JULY 2018 – The list of candidates for the next Regional Director of the Western Pacific was today sent by World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus to all Members of WHO’s Western Pacific Region. The candidates are as follows:
:: Dr Narimah Awin, proposed by Malaysia
:: Dr Takeshi Kasai, proposed by Japan
:: Dr Susan Mercado, proposed by the Philippines
:: Dr Colin Tukuitonga, proposed by New Zealand

CDC/ACIP [to 28 Jul 2018]

CDC/ACIP [to 28 Jul 2018]

Latest News
New Data Show Dramatic Progress in Namibia Toward HIV Epidemic Control and Substantial Gaps in Cote d’Ivoire and Cameroon

Wednesday, July 25, 2018
Statement from CDC Regarding Democratic Republic of Congo (DRC) Declaration on Official End of Ninth Ebola Outbreak
Tuesday, July 24, 2018
The U.S. Centers for Disease control and Prevention (CDC) commends the dedicated efforts of the Democratic Republic of Congo (DRC) Ministry of Public Health and partners to end the ninth reported outbreak of Ebola in that country since 1976. This good news reinforces the importance of having efficient surveillance systems in place and strong leadership to stop outbreaks at their source and save lives.
The DRC announcement, which was echoed by the World Health Organization, officially declares an end to the outbreak that began on May 8 in Bikoro Health Zone, Equateur Province, in Northwest DRC and resulted in 54 cases (38 cases laboratory confirmed and 16 deemed probable) and 33 deaths.
Working with international partners, CDC experts provided technical guidance on a range of crucial activities, including epidemiologic investigation, surveillance, infection prevention and control, border health screening, logistics and supplies, risk communication, and community engagement. CDC also assisted with vaccine implementation through a control effort that demonstrated the potential of an investigational vaccine, rVSV-ZEBOV, to prevent outbreak spread.
CDC has had a presence in DRC since 2002 and that long-term relationship, forged in science and nurtured in trust, has been instrumental in the fight against Ebola and other disease threats to people’s health and well-being.  By working collaboratively, DRC’s Ministry of Public Health has made significant progress in building capacity in disease detection and response. We must remain vigilant and continue efforts to tackle other outbreaks the country is facing, such as cholera and polio, and to strengthen health services across the country.

MMWR News Synopsis for July 26, 2018
Mumps Outbreaks at Four Universities — Indiana, 2016
Laboratory testing, implementation of control measures, and availability of vaccination records are essential elements of plans to manage and contain mumps outbreaks. This report highlights strategies used in multiple, nearly simultaneous university outbreaks of mumps in Indiana in 2016 that public health departments and partners could use to help prevent or manage similar outbreaks.
In 2016, the Indiana State Department of Health (ISDH) confirmed mumps outbreaks nearly simultaneously at four universities around the state that also spread into the community. The ISDH and local health departments began investigations and took steps to control the outbreaks. Among the 281 confirmed and probable cases of mumps identified, 205 (73.0%) people had received two verifiable doses of mumps vaccine and an additional 11 (3.9%) were immune to mumps by laboratory testing. Complications were infrequent among cases and only one person required hospitalization. No deaths were reported. These outbreaks highlighted discrepancies in immunization documentation at universities and challenges in controlling outbreaks in highly vaccinated populations.



Africa CDC   [to 28 Jul 2018]

Africa CDC   [to 28 Jul 2018]

July 26, 2018

Statement of the Chairperson of the African Union Commission on the end of the Ebola Outbreak in the Democratic Republic of Congo

Addis Ababa, 26 July 2018: The Chairperson of the Commission of the African Union, Moussa Faki Mahamat, welcomes the official announcement by the Government of the Democratic Republic of the Congo, on 24 July 2018, of the end of the Ebola virus outbreak in the country. He commends the Congolese Government for its swift and effective response since the outbreak was declared on 8 May 2018 in the province of Equateur. The last case that tested negative was 42 days ago. This, as per the World Health Organization guidelines and International Health Regulations, marks the end of the outbreak.

The Chairperson of the Commission notes that the timely declaration of the outbreak, in accordance with the International Health Regulations, as well as the leadership and pro-activeness demonstrated by the Congolese Government, allowed a coordinated and efficient intervention of all concerned partners to swiftly contain the outbreak.

The African Union Commission, through the Africa Centers for Disease Control and Prevention (Africa CDC), has made a significant contribution to the efforts aimed at containing the outbreak, in support of the Congolese-led response. The Africa CDC deployed health personnel in the affected areas, trained more than 300 local experts, procured diagnostic equipment, and supported the DRC Ministry of Health in central coordination of the response at national level.

The African Union will continue to support the efforts of the Congolese Government during the 90-day period of enhanced surveillance following the official end of the Ebola outbreak.




AERAS  [to 28 Jul 2018]

No new digest content identified.
BMGF – Gates Foundation  [to 28 Jul 2018]
No new digest content identified.

Bill & Melinda Gates Medical Research Institute    [to 28 Jul 2018]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

CARB-X   [to 28 Jul 2018]
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.

CEPI – Coalition for Epidemic Preparedness Innovations  [to 28 Jul 2018]
No new digest content identified.

EDCTP    [to 28 Jul 2018]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
No new digest content identified.

Emory Vaccine Center    [to 28 Jul 2018]
No new digest content identified.

European Medicines Agency  [to 28 Jul 2018]
[Website offline for maintenance at inquiry]
European Vaccine Initiative  [to 28 Jul 2018]
No new digest content identified.
FDA [to 28 Jul 2018]
No new digest content identified.

Fondation Merieux  [to 28 Jul 2018]
Mérieux Foundation event
Global challenges in vaccine acceptance science and programs
September 24 – 26, 2018 – Les Pensieres Center for Global Health, Veyrier du Lac (France)

Gavi [to 28 Jul 2018]
26 July 2018
Children in fragile states missing out on lifesaving vaccines
New vaccination figures show millions more children being immunised in world’s poorest countries.
[See Milestones/Perspectives above for more detail]

25 July 2018
Ebola vaccine praised as Congo outbreak declared over
DRC government officially declares end of outbreak following the vaccination of over 3,000 people.
[See Milestones/Perspectives above for more detail]
GHIT Fund   [to 28 Jul 2018]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical
No new digest content identified.

Global Fund [to 28 Jul 2018]
Global Fund Joins AIDS 2018 to Break Barriers and Build Bridges
25 July 2018
At the International AIDS Conference, the Global Fund to Fight AIDS, Tuberculosis and Malaria joined efforts to accelerate the end of the HIV epidemic, linking civil society, scientific experts and policymakers from all over the world on the conference theme of breaking barriers and building bridges.
Hilleman Laboratories   [to 28 Jul 2018]
No new digest content identified.
Human Vaccines Project   [to 28 Jul 2018]
No new digest content identified.
IAVI  [to 28 Jul 2018]
No new digest content identified.
No new digest content identified.

IVAC  [to 28 Jul 2018]
New Research: Using pneumococcal and rotavirus surveillance in vaccine decision-making: A series of case studies in Bangladesh, Armenia and the Gambia
July 2018
Through a series of country case studies, this paper reviews the successful use of surveillance data for disease caused by pneumococcus and rotavirus in informing national vaccine policy in Bangladesh, Armenia and The Gambia. The case studies delve into ways in which countries are leveraging and building capacity in existing surveillance infrastructure to monitor other diseases of concern in the country.
IVI   [to 28 Jul 2018]
IVI acquires $5 million grant to support process development, scale up of typhoid conjugate vaccine with SK Bioscience

– Grant from the Bill & Melinda Gates Foundation to allow SK Bioscience Co. Ltd, IVI to accelerate late-stage development of new vaccine necessary to achieve WHO prequalification

The International Vaccine Institute (IVI), an international nonprofit organization devoted to providing vaccines critical to global public health and based in Seoul, Korea, has been awarded a US$5 million grant from the Bill & Melinda Gates Foundation to support the development of a Vi-DT typhoid conjugate vaccine in collaboration with its manufacturer, SK Bioscience Co. Ltd..

The grant will support the process development and scale-up activities at SK Bioscience in preparation for a Phase III clinical trial prior to licensure and World Health Organization prequalification of the vaccine. Specifically, the grant will cover the cost of the Chemistry, Manufacturing, and Control (CMC) activities and process-validation batch production for the Phase III clinical trial. The phase I study of SK Vi-DT has already been completed in the Philippines and the vaccine was found to be safe and immunogenic. The phase II study is currently underway in the Philippines.

“This grant will allow SK and IVI to complete all activities critical to low-cost manufacturing and WHO prequalification of the Vi-DT conjugate,” said Dr. Sushant Sahastrabuddhe, Director of IVI’s Typhoid Program. “Through the project, we aim to ensure global supply and therefore access of the vaccine at an affordable price for populations in low and lower-middle income countries.”…

“Typhoid is a poverty-associated infectious disease. Like cholera, it strikes the impoverished and frequently occurs in low-income settings where there is a lack of access to clean water, and where sanitation and hygiene are poor. Infants and young children, in particular, are at risk,” said IVI’s Director General Dr. Jerome Kim. “IVI is proud to have developed a Vi-DT typhoid conjugate vaccine, and we will accelerate our collaboration with SK Bioscience to bring this vaccine to market and help achieve WHO prequalification; which will make it the second manufacturer of a TCV for the public health market.”

JEE Alliance  [to 28 Jul 2018]
No new digest content identified.
MSF/Médecins Sans Frontières  [to 28 Jul 2018]
Selected Press Releases/Statements
Sierra Leone
Winning people’s trust in healthcare
Project Update 27 Jul 2018

MSF opens emergency nutrition programme in N’Djamena
Press Release 27 Jul 2018

DRC 2018 Ebola outbreak
Ministry of Health declares Ebola epidemic over
Project Update 25 Jul 2018
…“Médecins Sans Frontières (MSF) welcomes this announcement and the end of the Ebola epidemic,” says MSF medical director Dr Micaela Serafini.
“Since the beginning of the outbreak, MSF set up its medical response along with national health authorities, providing care, isolation of patients and health promotion activities, in addition to participating in epidemiological surveillance and safe burials in Mbandaka, Bikoro, Itipo and Iboko.
Along with the Ministry of Health and the World Health Organization (WHO), MSF also participated in an investigational vaccination to hold off the spread of the virus. The data is still being analysed, but we are encouraged that this vaccination – as well as the rapid international response and concerted outreach efforts into remote communities – contributed to stemming the spread of this deadly virus. Vaccination provides an additional tool for fighting such epidemics…

Annual Report
International Activity Report 2017
24 Jul 2018

Stopping Senseless Deaths: Overcoming access barriers to affordable, lifesaving diagnostics and treatments for HIV and opportunistic infections
Report 23 Jul 2018
This technical brief analyses access barriers to affordable, lifesaving diagnostics and treatments for HIV and OIs, including adult and paediatric formulations of dolutegravir – a highly effective and tolerable HIV integrase inhibitor that replaces efavirenz in first-line treatment regimens. Updated antiretroviral drug pricing information is also provided.

Pfizer and GSK’s HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine [dolutegravir]
Press Release 23 Jul 2018

Towards Peer-Led HIV and SRH Services for Sex Workers and Men
Report 23 Jul 2018

Meeting the specific needs of key populations living with HIV
Project Update 23 Jul 2018

NIH  [to 28 Jul 2018]
July 25, 2018
Tickborne diseases are likely to increase, say NIH officials
Bacteria cause most tickborne diseases in the United States.

July 25, 2018
Fauci: HIV remission free of antiretroviral therapy is a feasible goal
NIAID director will give special session lecture at AIDS 2018 Conference.

July 24, 2018
NIH expands program that conducts large-scale clinical trials in real-world settings
Ongoing studies focus on many different diseases, including colon cancer, chronic pain and kidney failure.
The National Institutes of Health’s Health Care Systems (HCS) Research Collaboratory, which involves health care systems in conducting large-scale clinical studies, has announced five new research awards — totaling $4.15 million for a one-year planning phase, with an estimated $30.85 million expected for four subsequent years of study implementation. The HCS Research Collaboratory was developed by the NIH Common Fund in 2012 and is administered by the National Center for Complementary and Integrative Health (NCCIH) and the National Institute on Aging (NIA). The HCS Research Collaboratory is currently supporting nine large-scale clinical trials with health care systems across the United States, and a collaboratory coordinating center at Duke University, Durham, North Carolina. The ongoing trials focus on many different diseases, including colon cancer, chronic pain, kidney failure, hospital-acquired infections, suicide prevention, and multiple chronic medical conditions.
Health care systems, which include health maintenance organizations and other large integrated care settings, see large populations of patients. Through these collaborative research projects, NIH is also able to conduct large-scale and cost-effective clinical research on a variety of diseases within the settings where patients are already receiving their care.
“The collaboratory program pioneered efforts at NIH to conduct large-scale clinical trials within health care systems, and we are excited about expanding this initiative,” said David Shurtleff, Ph.D., NCCIH acting director. “Conducting clinical trials in real-world settings is a critical aspect of the collaboratory program.”
“This kind of trans-NIH collaboration is important as we test interventions on a large scale and in real world clinical care settings,” said Richard J. Hodes, M.D., director of NIA, who oversees the collaboratory with Shurtleff…


PATH  [to 28 Jul 2018]
No new digest content identified.


Sabin Vaccine Institute  [to 28 Jul 2018]
No new digest content identified.
UNAIDS [to 28 Jul 2018]
27 July 2018
Defending the rights of people living with HIV at community level in the Russian Federation

26 July 2018
How HIV treatment numbers are shown to be accurate
26 July 2018
Sustaining the HIV response in Latin America

25 July 2018
Reaching the 10-10-10 will put Europe on track to achieving the SDG targets

24 July 2018
Health leaders from 10 countries in eastern Europe and central Asia reaffirm commitment to scale up the AIDS response

24 July 2018
Global HIV Prevention Coalition implements the HIV Prevention 2020 Road Map


UNICEF  [to 28 Jul 2018]
Selected Press Releases/Reports/Statements
Press release
Rohingya refugee children face onset of deadly monsoon rains

Press release
Nearly 25 per cent of boys aged 15 out of school in the State of Palestine
Adolescent boys out of school due to the low quality of education, lack of relevance to their young lives, physical and emotional violence in schools, and conflict

Press release
Children affected by floods in Laos need urgent support
UNICEF and partners working to save lives and reach the most vulnerable children

Press release
Every three minutes a teenage girl is infected by HIV – UNICEF
Teenage girls bear brunt of a far-from-over HIV/AIDS epidemic

Access to water continues to be jeopardized for millions of children in war-torn Yemen
Statement attributable to Geert Cappelaere, UNICEF Regional Director in the Middle East and North Africa

Press release
DRC Ebola epidemic ends, but ongoing vigilance is essential to keeping children safe from future outbreaks – UNICEF

Vaccine Confidence Project  [to 28 Jul 2018]
No new digest content identified.

Vaccine Education Center – Children’s Hospital of Philadelphia  [to 28 Jul 2018]
Webinar registration open
Registration is now open for the next “Current Issues in Vaccines” webinar. Dr. Offit will speak about the following topics during the event scheduled for Wednesday, Sept. 5, 2018, at noon ET
Wellcome Trust  [to 28 Jul 2018]
News  / Published: 26 July 2018
Wellcome to use Researchfish for reporting research outcomes
From February 2019, Wellcome will ask most Science and Humanities & Social Science grantholders to use the Researchfish platform when reporting research outcomes at the end of their awards.
This will replace our current end-of-grant report, and will capture research outputs such as publications, intellectual property and software tools, and other outcomes such as influence on policy.
The change follows on from our announcement earlier this year about the Wellcome Success Framework, which set out nine ambitions that express what success looks like across all Wellcome’s work.
The data from Researchfish (opens in a new tab) will help us assess progress against these ambitions. It will be used at an aggregate level to gain a deeper understanding of what is being achieved through Wellcome grants and in partnership with others.
We won’t use it to assess the impact of individual grants, or to inform decisions about individual funding applications.
Collecting data in this way will also make it easier for research offices and researchers to record…

News / Published: 24 July 2018
Wellcome’s gender pay gap data for 2018
Today, we’re publishing our gender pay gap statistics which show a 17.4% median gender pay gap on 5 April 2018. This is an improvement on our 2017 gap of 20.8% and slightly better than the 2017 UK average of 18.4%.
The Wistar Institute   [to 28 Jul 2018]
No new digest content identified.


World Organisation for Animal Health (OIE)   [to 28 Jul 2018]
No new digest content identified.

BIO    [to 28 Jul 2018]
No new digest content identified.


DCVMN – Developing Country Vaccine Manufacturers Network  [to 28 Jul 2018]
No new digest content identified.


IFPMA   [to 28 Jul 2018]
No new digest content identified.

PhRMA    [to 28 Jul 2018]
No new digest content identified.

Reports/Research/Analysis/Commentary/Conferences/Meetings/Book Watch/Tenders

Reports/Research/Analysis/Commentary/Conferences/Meetings/Book Watch/Tenders

Vaccines and Global Health: The Week in Review has expanded its coverage of new reports, books, research and analysis published independent of the journal channel covered in Journal Watch below. Our interests span immunization and vaccines, as well as global public health, health governance, and associated themes. If you would like to suggest content to be included in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org


No new digest content identified.